Antibody-Mediated Fcγ Receptor-Based Mechanisms of HIV Inhibition: Recent Findings and New Vaccination Strategies - Test2 - elhamkhani - TriplyDB

Antibody-Mediated Fcγ Receptor-Based Mechanisms of HIV Inhibition: Recent Findings and New Vaccination Strategies

Antibody-Mediated Fcγ Receptor-Based Mechanisms of HIV Inhibition: Recent Findings and New Vaccination Strategies

http://www.wikidata.org/entity/Q30408097

about

Delayed treatment of Ebola virus infection with plant-derived monoclonal antibodies provides protection in rhesus macaques Which Antibody Functions are Important for an HIV Vaccine?Nonneutralizing functional antibodies: a new "old" paradigm for HIV vaccines HIV vaccine trial exploits a dual and central role for innate immunity.Rationally Designed Vaccines Targeting the V2 Region of HIV-1 gp120 Induce a Focused, Cross-Clade-Reactive, Biologically Functional Antibody Response.Rapid high-level production of functional HIV broadly neutralizing monoclonal antibodies in transient plant expression systems Glycan modulation and sulfoengineering of anti-HIV-1 monoclonal antibody PG9 in plants.New prospects for a preventive HIV-1 vaccine.Rhesus macaques vaccinated with consensus envelopes elicit partially protective immune responses against SHIV SF162p4 challenge.HIV-1 specific antibody titers and neutralization among chronically infected patients on long-term suppressive antiretroviral therapy (ART): a cross-sectional study.HIV-specific antibody-dependent cellular cytotoxicity: a novel vaccine modality.Role of Fc-mediated antibody function in protective immunity against HIV-1.Highly individual patterns of virus-immune IgG effector responses in humans.Antibody Functional Assays as Measures of Fc Receptor-Mediated Immunity to HIV - New Technologies and their Impact on the HIV Vaccine Field.Non-Neutralizing Antibodies Directed against HIV and Their Functions.

P2860

Q24612811-DBAC8889-7006-4835-AF11-926B2A1FB97C Q33772637-7048B700-02CF-4ADC-8690-ADC4A137CED1 Q34057711-CE3AE641-F614-4CBB-9F05-4982ED2CCC04 Q34261579-7E4C820A-9042-44A6-AC4E-A940865C26D1 Q34540352-1B3E1E8A-63D5-427B-83A3-964C28E87608 Q34637663-7BE0103F-C86E-42A4-B787-115D45337307 Q36179265-340F927B-4D58-4308-85C5-2D8EBD0D341A Q36223864-26F7C99D-69DA-4FA7-9E6B-62B46A4B8602 Q36798324-CE3A29CA-9C90-462B-9D19-A0B030D980D6 Q37484124-B3A233BA-6724-4E33-9DA5-65723F6C6CA3 Q38061191-89CBBE47-B9F4-44E3-A1E6-4879F2319675 Q38213061-501B24A2-03EA-4ACB-B87F-36BF223867D0 Q38953491-342D3976-2EBB-4A8A-8246-8EBF849149B6 Q39189458-B442B400-8EB0-469B-84F5-472C639ADFF2 Q47139556-7DEEC708-9093-46E3-823B-249C362F04F6

P2860

Antibody-Mediated Fcγ Receptor-Based Mechanisms of HIV Inhibition: Recent Findings and New Vaccination Strategies

http://www.wikidata.org/entity/Q30408097

description

2009 nî lūn-bûn

@nan

2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Antibody-Mediated Fcγ Receptor ...... and New Vaccination Strategies

@ast

Antibody-Mediated Fcγ Receptor ...... and New Vaccination Strategies

@en

type

label

Antibody-Mediated Fcγ Receptor ...... and New Vaccination Strategies

@ast

Antibody-Mediated Fcγ Receptor ...... and New Vaccination Strategies

@en

prefLabel

Antibody-Mediated Fcγ Receptor ...... and New Vaccination Strategies

@ast

Antibody-Mediated Fcγ Receptor ...... and New Vaccination Strategies

@en

P1433

Q30408097-CFDAB36F-D217-48D0-A463-F910FC12E01F

P1476

Q30408097-7417B727-60AF-48D5-B2B4-93CDF6E81F47

P2093

Q30408097-27E201C4-EE15-48D5-9C2E-7C8616FC5D7C

Q30408097-6AB51EB4-404D-4CA9-9D11-F980564CCF91

Q30408097-ECBCB28F-3206-4F3B-9274-74B57D7D3DFD

P2860

Q30408097-00DD603A-F1AC-4784-9C04-A51F802DADDE

Q30408097-013B4870-7B2F-4FC0-9F51-43D5BA9B09D3

Q30408097-0296A052-C7E2-465D-8132-127859A90635

Q30408097-02C68F74-52F7-4A5A-A8B7-9F6014CE8CF2

Q30408097-0438ED1D-3557-4456-AF6B-AAC416F13000

Q30408097-0454B318-AF79-47DA-B31A-AFDE58284417

Q30408097-06BB4961-7458-476D-8E69-4328EB990BBC

Q30408097-06EEE4F2-2909-42A4-AD33-4E23D4C18F4A

Q30408097-09E8B3FE-0C23-477B-AAB5-AF79BC0535CA

Q30408097-11F43934-75CA-4A1B-95FC-53EADCD5522A

P304

Q30408097-B04EE7AE-9CAA-4C1B-8B08-C449F2A66A8F

P31

Q30408097-E1EB25BD-13C6-4F6E-96BD-3510E20DD0D3

P356

Q30408097-B9414E1D-F05D-4878-91C3-9E6F7FF66809

P433

Q30408097-3DF6AEC9-9D1C-4289-B475-235FC6FEAEF2

P478

Q30408097-A33FC9E7-D1FF-4173-BAC5-31456E940832

P577

Q30408097-2E9449A4-FDE3-4676-A951-1CF43F778E0B

P5875

Q30408097-6D8A80E6-F8ED-44DC-A7A7-E3CE254A72AA

P698

Q30408097-A3CDE0F3-FCD5-4299-B0B7-7D00F7E99CE8

P921

Q30408097-01FFE9B0-7166-4CE6-ABFD-63F74F8B3192

P932

Q30408097-F57CA3B3-1015-436E-B00C-F1AC08FBDD55

P356

P1433

P1476

Antibody-Mediated Fcγ Receptor ...... and New Vaccination Strategies

@en

P2093

Christiane Moog

http://www.w3.org/2001/XMLSchema#string

Maryse Peressin

http://www.w3.org/2001/XMLSchema#string

Vincent Holl

http://www.w3.org/2001/XMLSchema#string

P2860

A large array of human monoclonal antibodies to type 1 human immunodeficiency virus from combinatorial libraries of asymptomatic seropositive individuals

Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies

Antibodies against West Nile Virus Nonstructural Protein NS1 Prevent Lethal Infection through Fc Receptor-Dependent and -Independent Mechanisms

Antibody Recognition of Cell Surface-Associated NS1 Triggers Fc- Receptor-Mediated Phagocytosis and Clearance of West Nile Virus-Infected Cells

Crystal structure of a neutralizing human IGG against HIV-1: a template for vaccine design

Structural analysis of human IgG-Fc glycoforms reveals a correlation between glycosylation and structural integrity

Broad and potent neutralizing antibodies from an African donor reveal a new HIV-1 vaccine target

Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies

Fcgamma receptors as regulators of immune responses

Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1

P304

1265-1294

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3390/V1031265

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

1

http://www.w3.org/2001/XMLSchema#string

P577

2009-12-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

40755410

http://www.w3.org/2001/XMLSchema#string

P698

21994593

http://www.w3.org/2001/XMLSchema#string

P921

P932

3185537

http://www.w3.org/2001/XMLSchema#string